Per Artikel

Riset dan Pengabdian Masyarakat Do Research Sosial Service and Innovation

Id	Authors	Author S Id	Title	Year	Source Title	Volume	Issue	Art No	Page Start	Page End	Cited By	Link	Affiliations	Authors With Affiliations	Abstract	Author Keywords	Index Keywords	Publisher	Issn	Pubmed Id	Document Type	Sjr Best Quartile	Sjr	Sjr Rank
Display # Page 86 of 93 Start Prev 81 82 83 84 85 86 87 88 89 90 Next End
Termedia Publishing House Ltd.(1)
No records
892	Dwinata M., Putera D.D., Hasan I., Raharjo M.	57209231012;57210288025;12776850800;57212400550;	SGLT2 inhibitors for improving hepatic fibrosis and steatosis in non-alcoholic fatty liver disease complicated with type 2 diabetes mellitus: a systematic review	2021	Clinical and Experimental Hepatology	6	4		339	346	1	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099931230&doi=10.5114%2fceh.2020.102173&partnerID=40&md5=628a477d8f6d02f9de989db2ce816c8c	Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia; Hepatobiliary Division, Department of Internal Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia	Dwinata, M., Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia; Putera, D.D., Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Yogyakarta, Indonesia; Hasan, I., Hepatobiliary Division, Department of Internal Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Raharjo, M., Hepatobiliary Division, Department of Internal Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia	Aim of the study: To evaluate the efficacy of sodium/glucose cotransporter-2 inhibitors (SGLT2i) in improving hepatic fibrosis and steatosis of non-alcoholic fatty liver disease (NAFLD) patients with type 2 diabetes mellitus (T2DM). Material and methods: We searched CENTRAL, MEDLINE, and EMBASE and included any clinical trials involving patients with NAFLD and T2DM aged ≥ 18 years comparing efficacy of SGLT2i and other antidiabetic drugs in improving fibrosis and steatosis, irrespective of publication status, year of publication, and language. Results: Five clinical trials were included. One study reported significant improvements in the controlled attenuation parameter 314.6 ±61.0 dB/m to 290.3 ±72.7 dB/m (p = 0.04) in the SGLT2i group measured by transient elastography. In patients with significant fibrosis, dapagliflozin treatment significantly decreased the liver stiffness measurement from 14.7 ±5.7 kPa at baseline to 11.0 ±7.3 kPa after 24 weeks (p = 0.02). One study reported a significant decrease in liver fat content 16.2% to 11.3% (p < 0.001) in the SGLT2i group compared to the control (p < 0.001). Three studies reported significant improvement in the liver-to-spleen ratio in the SGLT2i group after treatment 0.96 (0.86-1.07) to 1.07 (0.98-1.14), p < 0.01, 0.80 ±0.24 to 1.00 ±0.18, p < 0.001, and 0.91 (0.64-1.04) to 1.03 (0.80-1.20), p < 0.001 respectively. All studies reported a significant decrease in alanine aminotransferase with SGLT2i. Conclusions: SGLT2i is associated with positive effects on hepatic steatosis measured by non-invasive modalities. Further studies are needed to confirm the impact of SGLT2i on hepatic fibrosis and steatosis. © 2020 Termedia Publishing House Ltd.. All rights reserved.	Diabetes mellitus; Fibrosis; NAFLD; SGLT2 inhibitor; Steatosis	alanine aminotransferase; dapagliflozin; empagliflozin; ipragliflozin; luseogliflozin; metformin; pioglitazone; sodium glucose cotransporter 2 inhibitor; adult; aged; alanine aminotransferase blood level; Article; comparative effectiveness; controlled study; diabetic patient; drug efficacy; elastography; female; human; liver fibrosis; liver stiffness; major clinical study; male; middle aged; non insulin dependent diabetes mellitus; nonalcoholic fatty liver; quasi experimental study; randomized controlled trial; systematic review; transient elastography; treatment outcome	Termedia Publishing House Ltd.	23921099		Article	Q4	394	12273	View
The Indonesian Foundation of Critical Care Medicine(3)
No records
357	Yuniar I.	57222295046;	Restrictive versus liberal fluid bolus therapy in septic shock children: An evidence-based case report	2021	Critical Care and Shock	24	3		143	152		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85108644226&partnerID=40&md5=42389d8b506d8b4bbacd5ec1431f9c34	Division of Pediatric Emergency and Hospitalization, Departement of Child Health, dr. Cipto, Mangunkusumo General Hospital, Faculty of Medicine, University of Indonesia, Indonesia	Yuniar, I., Division of Pediatric Emergency and Hospitalization, Departement of Child Health, dr. Cipto, Mangunkusumo General Hospital, Faculty of Medicine, University of Indonesia, Indonesia	Fluid bolus therapy (FBT) is one of prime management in early goal-directed therapy (EGDT) to achieve adequate cardiac output. The Fluid Expansion as Supportive Therapy (FEAST) tri-al, a randomized-clinical trial that was used as an evidence to support fluid resuscitation rec-ommendation in Surviving Sepsis Campaign (SSC) 2020, must be discontinued because of . increasing mortality in the group that received higher volume of FBT. We present a case of a 9-year-old girl, 15 kg, came to emergency ward with refractory septic shock and became fluid overload after the second FBT. This proceeding aimed to deliver evidence-based case practice if the comparison between liberal versus restrictive FBT in children with septic shock. © 2021, The Indonesian Foundation of Critical Care Medicine. All rights reserved.	Fluid; Liberal; Pediatric; Restrictive; Resuscitation; Shock	cefotaxime; dobutamine; furosemide; oxygen; paracetamol; procalcitonin; Ringer lactate solution; vasoactive agent; Article; case report; child; clinical article; comparative effectiveness; drug dose titration; dyspnea; early goal-directed therapy; emergency ward; evidence based practice; female; fluid bolus therapy; fluid resuscitation; forward heart failure; heart afterload; heart muscle contractility; heart preload; hemodynamic monitoring; human; hypervolemia; hypotension; hypovolemic shock; mortality; pediatric intensive care unit; pericardial effusion; school child; septic shock; tachycardia	The Indonesian Foundation of Critical Care Medicine	14107767		Article	Q4	134	24890	View
679	Akbar R., George Y., Madjid A.S., Sedono R., Tantri A.	57317624300;26027840300;57163353500;56660590500;57188933853;	Early administration of norepinephrine prevents the occurrence of fluid overload in the resuscitation of septic shock patients	2021	Critical Care and Shock	September 2021			257	268		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85118270800&partnerID=40&md5=d27a72a8961cf30e6da6e5952895aa23	Trainee of Intensive Care Fellowship Program, University of Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Medical Faculty, Haluoleo University-Konawe General Hos-pital, Konawe, Indonesia; Emergency and Intensive Care Unit-Pondok Indah Hospital Jakarta and Departement of Anesthesiology and Intensive Therapy-Faculty of Medicine Universitas, Indonesia; Department of Anesthesiology and Intensive Care, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia	Akbar, R., Trainee of Intensive Care Fellowship Program, University of Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Medical Faculty, Haluoleo University-Konawe General Hos-pital, Konawe, Indonesia; George, Y., Emergency and Intensive Care Unit-Pondok Indah Hospital Jakarta and Departement of Anesthesiology and Intensive Therapy-Faculty of Medicine Universitas, Indonesia; Madjid, A.S., Department of Anesthesiology and Intensive Care, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia; Sedono, R., Department of Anesthesiology and Intensive Care, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia; Tantri, A., Department of Anesthesiology and Intensive Care, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia	Background: Critically ill patients with sepsis usually receive a very large volume of fluids cau-sing a very significant positive fluid balance in an effort to meet the needs of cardiac output, syste-mic blood pressure, and perfusion to the kidneys. This condition also tends to be associated with poor survival rates. The aim of this study was to determine whether early maintenance of norepi-nephrine can reduce fluid administration and prevent overload in the resuscitation of patients with septic shock. Methods: This study was a randomized, non-blind clinical trial, of which the subjects were adult patients with septic shock admitted to the intensive and emergency care unit from January to November 2020. There were two treatment groups of this study, the early norepinephrine group (NEP group) and the 30 ml/kgBW fluid resuscitation one (Fluid group). The test was con-ducted on the urinary albumin-to-creatinine ra-tio, increase of serum creatinine value, ratio of arterial oxygen partial pressure to fractional in-spired oxygen (PaO2/FiO2 ratio), and intra-ab-dominal pressure at the time of septic shock di-agnosis was established, 3 hours, and 24 hours . after the treatment was given. The data was pro-cessed using the SPSS device. Results: Based on the analysis, it was found that there were significant differences in all study va-riables of the Fluid group compared to the NEP group. The amount of fluid administration in the NEP group averaged 2198.63 ml, less than that in the Fluid group with an average of 3999.30 ml (chi square test p=0.000). By comparing the measurement results to the initial measurement values in the two groups, the fluid overload was high-risk in the Fluid group. There was a significant relationship between the urinary albumin-to-creatinine ratio (OR=48.273; 95% CI=16.708-139.472), the increase in serum crea-tinine value (OR=73.381; 95% CI=19.955-269.849), the low PaO2/FiO2 ratio (OR=12.225; 95% CI=5.290-28.252), and the increase in intra-abdominal pressure (OR=32.667; 95% CI=10.490-101.724) with the provision of 30 ml/kgBW fluid resuscitation, which indicated the risk of fluid overload. Conclusion: Early norepinephrine administration can reduce fluid administration and prevent overload in the resuscitation of patients with septic shock. © 2021, The Indonesian Foundation of Critical Care Medicine. All rights reserved.	Early norepinephrine; Fluid overload; Septic shock	noradrenalin; abdominal pressure; adult; aged; albumin to creatinine ratio; albuminuria; Article; blood volume; capillary leak syndrome; controlled study; creatinine blood level; emergency care; female; fraction of inspired oxygen; Horowitz index; human; hypervolemia; intensive care; major clinical study; male; randomized controlled trial; resuscitation; risk; septic shock; Sequential Organ Failure Assessment Score; systolic blood pressure	The Indonesian Foundation of Critical Care Medicine	14107767		Article	Q4	134	24890	View
734	Pudjiadi A.H.	18435202300;	Sepsis-induced T-cell suppression in pediatric sepsis	2021	Critical Care and Shock	2021	July		172	180		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112603065&partnerID=40&md5=f1958f220fe6de69e13b086f449c61df	Department of Child Health, Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Pudjiadi, A.H., Department of Child Health, Cipto Mangunkusumo Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia	Sepsis contributes to significant mortality and morbidity in children. Despite rigorous resusci-tation effort, adequate antibiotics and advanced medical support, a significant proportion still face mortality due to multiple organ failure. Re-. cent hypothesis suggests host’s immune response pathology in the form of compensatory anti-in-flammatory response syndrome (CARS). This review aims to elucidate the pathophysiology of immune paralysis, both affecting innate and acquired immunity. © 2021, The Indonesian Foundation of Critical Care Medicine. All rights reserved.	Compensatory anti-inflammatory response syndrome; HLA-DR; Immunoparalysis; Sepsis; TNF-α		The Indonesian Foundation of Critical Care Medicine	14107767		Review	Q4	134	24890	View
Thieme Medical Publishers, Inc.(6)
No records
252	Reksodiputro M.H., Hutauruk S.M., Widodo D.W., Fardizza F., Mutia D.	35090488800;57205105620;56644646600;55091031700;57221630137;	Response to Letter by Spartalis et al: Platelet-Rich Fibrin in Total Laryngectomy: Further Study Concerns	2021	Facial Plastic Surgery	37	4		551	552		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85111071840&doi=10.1055%2fs-0041-1729637&partnerID=40&md5=8aeb911188e8d4c1c7a3fd0986d70915	Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia; Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia	Reksodiputro, M.H., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Hutauruk, S.M., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Widodo, D.W., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Fardizza, F., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia, Division of Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Rumah Sakit Umum Pusat Nasional Dr Cipto Mangunkusumo, Central Jakarta, DKI Jakarta, Indonesia; Mutia, D., Department of Otorhinolaryngology-Head and Neck Surgery, Plastic Reconstructive Division, Faculty of Medicine, University of Indonesia, Jl Diponegoro No 71, DKI Jakarta, Jakarta, 10413, Indonesia	[No abstract available]		platelet-rich fibrin; human; laryngectomy; Humans; Laryngectomy; Platelet-Rich Fibrin	Thieme Medical Publishers, Inc.	07366825	34284502	Letter	Q3	435	11329	View
377	Dharma S., Dakota I., Firdaus I., Danny S.S., Zamroni D., Yudha A., Susanto A., Siswanto B.B.	55101301700;55796663700;55796864700;56221848700;57215684617;57223107725;57225841633;14422648800;	Performance of Primary Angioplasty for STEMI during the COVID-19 Outbreak	2021	International Journal of Angiology	30	2	210001	148	154	1	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104870014&doi=10.1055%2fs-0041-1727133&partnerID=40&md5=5b349c0b1a14cb4af4bcc5b822d2e435	Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jl S Parman Kav 87, Slipi, Jakarta Barat, Jakarta, 11420, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Catheterization Laboratory Nurse Manager, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia	Dharma, S., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jl S Parman Kav 87, Slipi, Jakarta Barat, Jakarta, 11420, Indonesia; Dakota, I., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Firdaus, I., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Danny, S.S., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Zamroni, D., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Yudha, A., Indonesian Cardiovascular Research Center, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Susanto, A., Catheterization Laboratory Nurse Manager, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia; Siswanto, B.B., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center Harapan Kita, Jakarta, Indonesia	There has been concern whether the declining cases of ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) outbreak associate with primary angioplasty performance. We assessed the performance of primary angioplasty in a tertiary care hospital in Jakarta, Indonesia, by comparing the door-to-device (DTD) time and thrombolysis in myocardial infarction (TIMI) flow after angioplasty between two periods of admission: during the outbreak of COVID-19 (March 1 to May 31, 2020) and before the outbreak (March 1, to May 31, 2019). Overall, there was a relative reduction of 44% for STEMI admission during the outbreak (n = 116) compared with before the outbreak (N = 208). Compared with before the outbreak period (n = 141), STEMI patients who admitted during the outbreak and received primary angioplasty (n = 70) had similar median symptom onset-to-angioplasty center admission (360 minutes for each group), similar to radial access uptake (90 vs. 89.4%, p = 0.88) and left anterior descending infarct-related artery (54.3 vs. 58.9%, p = 0.52). The median DTD time and total ischemia time were longer (104 vs. 81 minutes, p < 0.001, and 475.5 vs. 449 minutes, p = 0.43, respectively). However, the final achievement of TIMI 3 flow was similar (87.1 vs. 87.2%), and so was the in-hospital mortality (5.7 vs. 7.8%). During the COVID-19 outbreak, we found a longer DTD time for primary angioplasty, but the achievement of final TIMI 3 flow and in-hospital mortality were similar as compared with before the outbreak. Thus, primary angioplasty should remain the standard of care for STEMI during the COVID-19 outbreak. © 2020. International College of Angiology. All rights reserved.	COVID-19 outbreak; performance measures; primary angioplasty	acetylsalicylic acid; angiotensin receptor antagonist; beta adrenergic receptor blocking agent; clopidogrel; creatinine; dipeptidyl carboxypeptidase inhibitor; heparin; salicylic acid; simvastatin; ticagrelor; adult; angioplasty; Article; cardiovascular risk factor; catheterization; controlled study; coronary angiography; coronavirus disease 2019; creatinine blood level; door to device time; emergency ward; epidemic; female; fibrinolytic therapy; health care utilization; heart left bundle branch block; hospital admission; hospital discharge; human; in-hospital mortality; Indonesia; information processing; ischemia time; length of stay; major clinical study; male; non ST segment elevation myocardial infarction; observational study; outcome assessment; percutaneous coronary intervention; pos	Thieme Medical Publishers, Inc.	10611711		Article	Q3	293	15070	View
385	Silalahi T., Alwi I., Suyatna F., Sartika K.D.	56275255400;15055173800;57303311300;57221849323;	Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease	2021	International Journal of Angiology	30	2	200063	132	138		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100412387&doi=10.1055%2fs-0040-1720969&partnerID=40&md5=d55e2b0c365eafd1a179c7602474794d	Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia; Division Cardiovascular, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Department of Clinical Pharmacology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia	Silalahi, T., Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia; Alwi, I., Division Cardiovascular, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Suyatna, F., Department of Clinical Pharmacology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia; Sartika, K.D., Division of Cardiovascular, Department of Internal Medicine, Faculty of Medicine Krida Wacana Christian University, Cipto Mangunkusumo National General Hospital, Arjuna Utara Street No. 6, Duri Kepa, Kebon Jeruk, Jakarta, 11510, Indonesia	Cardiovascular diseases play major roles in the health problems worldwide especially in Indonesia. Percutaneous coronary intervention (PCI) is a minimally invasive procedure with relatively low complications. However, high inflammatory response post-PCI has showed adverse events even after administration of standard medication. Previous studies showed that curcumin was able to reduce inflammatory response in adult patients with stable coronary heart disease (CHD). This article determines the efficacy of oral administration of curcumin in reducing inflammatory response post-PCI with stable CHD. A double-blind randomized controlled trial on 50 adult patients comparing curcumin and placebo was performed in Cipto Mangunkusumo General Hospital and Jakarta Heart Center within April and June 2015. Either curcumin (45 mg/day) or placebo was given 7 days prior to PCI until 2 days after PCI. Inflammatory markers (high-sensitivity C-reactive protein [hsCRP] and soluble CD40 ligand [sCD40L]) were measured in three phases (7 days prior PCI, 24 hours post-PCI, and 48 hours post-PCI). There were no significant differences in the reduction of hsCRP and sCD40L between curcumin and placebo groups in three phases of measurement. Curcumin significantly reduce the serum hsCRP (p = 0.006) and sCD40L (p = 0.002) 7 days before PCI to 48 hours post-PCI. The decrement of hsCRP (-14.2% vs. -7.4%) and sCD40L (-24.3% vs. -13.2%) from 24 to 48 hours post-PCI was higher in the curcumin group than placebo group. The administration of curcumin 45 mg dose daily for 7 days prior PCI until 48 hours post-PCI is useful in reducing inflammatory response post-PCI with stable CHD. © 2020. International College of Angiology. All rights reserved.	curcumin; inflammatory response; PCI; stable CHD	acetylsalicylic acid; C reactive protein; CD40 ligand; clopidogrel; curcumin; placebo; adult; Article; clinical article; controlled study; dose response; double blind procedure; drug efficacy; female; human; human tissue; inflammatory disease; ischemic heart disease; male; measurement; middle aged; percutaneous coronary intervention; priority journal; protein blood level; randomized controlled trial; treatment response	Thieme Medical Publishers, Inc.	10611711		Article	Q3	293	15070	View
387	Reksodiputro M.H., Hutauruk S.M., Widodo D.W., Fardizza F., Mutia D.	35090488800;57205105620;56644646600;55091031700;57221630137;	Platelet-Rich Fibrin Enhances Surgical Wound Healing in Total Laryngectomy	2021	Facial Plastic Surgery	37	3		325	332		https://www.scopus.com/inward/record.uri?eid=2-s2.0-85099660024&doi=10.1055%2fs-0040-1717083&partnerID=40&md5=43744ae74dd367876ae8b58289232fb6	Division of Facial Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Division of Larynx Pharynx, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia	Reksodiputro, M.H., Division of Facial Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Hutauruk, S.M., Division of Larynx Pharynx, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Widodo, D.W., Division of Facial Plastic Reconstructive, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Fardizza, F., Division of Larynx Pharynx, Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia; Mutia, D., Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital, Universitas Indonesia, Jakarta, Indonesia	Autologous growth factor (AGF) is a cytokine that has gained medical research interest because it helps improve and accelerate the wound healing process. Platelet-rich fibrin (PRF) is the latest generation of platelet concentrate that can be obtained through a simple procedure known as AGF referencing. One of the most common complications of total laryngectomy (TL) is pharyngocutaneous fistula. To prevent this complication, health care providers must closely monitor the postoperative wound healing process.This study aimed to investigate the effectiveness of PRF application in enhancing wound healing after TL. A randomized controlled trial was conducted in the Department of Otorhinolaryngology - Head and Neck Surgery, Faculty of Medicine, Dr. Cipto Mangunkusumo Hospital Universitas Indonesia, Jakarta, Indonesia, from June 2019 to December 2019. We included 20 patients who underwent TL for laryngeal squamous cell carcinoma. They were divided into two groups (10 patients who received applied autologous PRF around the esophageal stoma during TL and another 10 patients as the control). These patients were observed for 2 weeks postoperatively. In the bivariate analysis performed using the chi-square test, the pain threshold and edema of postoperative wounds in the PRF-treated group demonstrated significant differences compared with those in the control group. PRF application in TL enhanced the postoperative wound healing process, especially with regard to edema and pain. © 2021 Thieme Medical Publishers, Inc.. All rights reserved.	pharyngocutaneous fistula; platelet-rich fibrin; PRF; total laryngectomy	platelet-rich fibrin; controlled study; human; laryngectomy; randomized controlled trial; surgical wound; wound healing; Humans; Laryngectomy; Platelet-Rich Fibrin; Surgical Wound; Wound Healing	Thieme Medical Publishers, Inc.	07366825	33445196	Article	Q3	435	11329	View
695	Adiarto S., Kurnianingsih N., Prasetya I., Nugroho F.W., Uberoi R.	8603606800;57223044495;56725585200;57290221600;22136581000;	Successful Primary PCI in Stanford Type A Aortic Dissection Complicated by Inferior ST-Elevation Myocardial Infarction: A Case in a Facility with No Surgical Backup	2021	International Journal of Angiology							https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116762000&doi=10.1055%2fs-0041-1735205&partnerID=40&md5=3716852a47a6df47d93b73adfb8623d6	Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Harapan Kita National Cardiovascular Center, Jl. Letjen S. Parman Kav. 87 Slipi, Jakarta, 11420, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine Brawijaya University, Dr. Saiful Anwar Hospital, East Java, Malang, Indonesia; Department of Radiology, John Radcliffe Hospital, Headington, Oxford, United Kingdom	Adiarto, S., Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia, Harapan Kita National Cardiovascular Center, Jl. Letjen S. Parman Kav. 87 Slipi, Jakarta, 11420, Indonesia; Kurnianingsih, N., Department of Cardiology and Vascular Medicine, Faculty of Medicine Brawijaya University, Dr. Saiful Anwar Hospital, East Java, Malang, Indonesia; Prasetya, I., Department of Cardiology and Vascular Medicine, Faculty of Medicine Brawijaya University, Dr. Saiful Anwar Hospital, East Java, Malang, Indonesia; Nugroho, F.W., Department of Cardiology and Vascular Medicine, Faculty of Medicine Brawijaya University, Dr. Saiful Anwar Hospital, East Java, Malang, Indonesia; Uberoi, R., Department of Radiology, John Radcliffe Hospital, Headington, Oxford, United Kingdom	Mortality of type A aortic dissection (TAAD) complicated with coronary malperfusion syndrome is very high even when emergency surgery is performed. Several reports suggested that primary percutaneous coronary intervention (PPCI) followed by immediate corrective surgery may reduce mortality. In many countries, immediate transfer to an aortic surgery center may not be possible. We report a case of TAAD complicated by coronary malperfusion successfully treated with PPCI followed by elective corrective surgery. A 48-year-old man was referred to emergency department with acute inferior ST-elevation myocardial infarction (STEMI) and underwent PPCI. During the procedure, we realized that the cause of STEMI was TAAD. We decided to continue because the patient experienced seizures and bradycardia. Subsequently, echocardiography and computed tomography confirmed the dissection. The patient was discharged and referred to the National Cardiovascular Center where he underwent successful elective surgery. In this patient, immediate revascularization was lifesaving and served as a bridging procedure before surgical correction. © 2021 Georg Thieme Verlag. All rights reserved.	aortic dissection; coronary intervention; coronary malperfusion syndrome; malperfusion syndrome; primary PCI; STEMI; type A aortic dissection		Thieme Medical Publishers, Inc.	10611711		Article	Q3	293	15070	View
696	Nugraha R.A., Muliawan H.S., Nugroho N.T., Ikhsan M., Adiarto S.	57220785065;57203644653;57211452795;57291104400;8603606800;	Catastrophic Concomitant Arterial and Venous Thrombosis in a Mild COVID-19-Positive Patient	2021	International Journal of Angiology							https://www.scopus.com/inward/record.uri?eid=2-s2.0-85116737806&doi=10.1055%2fs-0041-1735200&partnerID=40&md5=35939b91c7ecfee83d98ad94c4b7e884	Department of General Medicine, Universitas Indonesia Hospital, Universitas Indonesia, Jl. Prof Bahder Djohan, Pondok Cina, Beji, Depok, 16424, Indonesia; Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, Universitas Indonesia Hospital, Depok, Indonesia; Department of Vascular and Endovascular Surgery, Cipto Mangunkusumo Hospital, Universitas Indonesia Hospital, Depok, Indonesia; Department of Internal Medicine, Cipto Mangunkusumo Hospital, Universitas Indonesia Hospital, Depok, Indonesia	Nugraha, R.A., Department of General Medicine, Universitas Indonesia Hospital, Universitas Indonesia, Jl. Prof Bahder Djohan, Pondok Cina, Beji, Depok, 16424, Indonesia; Muliawan, H.S., Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, Universitas Indonesia Hospital, Depok, Indonesia; Nugroho, N.T., Department of Vascular and Endovascular Surgery, Cipto Mangunkusumo Hospital, Universitas Indonesia Hospital, Depok, Indonesia; Ikhsan, M., Department of Internal Medicine, Cipto Mangunkusumo Hospital, Universitas Indonesia Hospital, Depok, Indonesia; Adiarto, S., Department of Cardiology and Vascular Medicine, National Cardiovascular Center Harapan Kita, Universitas Indonesia Hospital, Depok, Indonesia	Since its first discovery in late 2019, coronavirus disease 2019 (COVID-19) has been a global burden associated with significant morbidity and mortality. COVID-19 has been correlated with the development of hypercoagulable state that predisposes the patients to a higher risk of thromboembolism. Current evidence suggests higher incidence of thrombosis, particularly venous thrombosis, among hospitalized COVID-19 patients, mostly with critical illness. On the other hand, there is currently no data regarding the incidence of vivid thrombosis in ambulatory patients with mild COVID-19 and the incidence of concomitant arterial and venous thrombosis in COVID-19 is extremely rare. Herein, we describe catastrophic outcomes of concomitant lower limb arterial and venous thrombosis in a patient with mild COVID-19. This report highlights the occurrence of concomitant arterial and venous thrombosis in ambulatory setting and that this phenomenon resulted in catastrophic clinical consequences. © 2021 Georg Thieme Verlag. All rights reserved.	acute limb ischemia; ambulatory; anticoagulation; deep vein thrombosis; ischemia-reperfusion injury; mild COVID-19; thrombectomy		Thieme Medical Publishers, Inc.	10611711		Article	Q3	293	15070	View

Publikasi Scopus 926 artikel (Per 14 Maret 2022)